| Literature DB >> 24672698 |
Athanasios Madesis1, Kosmas Tsakiridis1, Paul Zarogoulidis1, Nikolaos Katsikogiannis1, Nikolaos Machairiotis1, Ioanna Kougioumtzi1, George Kesisis1, Theodora Tsiouda1, Thomas Beleveslis1, Alexander Koletas1, Konstantinos Zarogoulidis1.
Abstract
Mitral valve (MV) dysfunction is the second-most common clinically significant form of valvular defect in adults. MV regurgitation occurs with the increasing frequency of degenerative changes of the aging process. Moreover, other causes of clinically significant MV regurgitation include cardiac ischemia, infective endocarditis and rhematic disease more frequently in less developed countries. Recent evidence suggests that the best outcomes after repair of severe degenerative mitral regurgitation (MR) are achieved in asymptomatic or minimally symptomatic patients, who are selected for surgery soon after diagnosis on the basis of echocardiography. This review will focus on the surgical management of mitral insufficiency according to its aetiology today and will give insight to some of the perspectives that lay in the future.Entities:
Keywords: Mitral valve (MV); cardiothoracic surgery; interventional surgery
Year: 2014 PMID: 24672698 PMCID: PMC3966162 DOI: 10.3978/j.issn.2072-1439.2013.10.20
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895